These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
339 related items for PubMed ID: 14680360
1. Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancer. Sharma P, Gnjatic S, Jungbluth AA, Williamson B, Herr H, Stockert E, Dalbagni G, Donat SM, Reuter VE, Santiago D, Chen YT, Bajorin DF, Old LJ. Cancer Immun; 2003 Dec 18; 3():19. PubMed ID: 14680360 [Abstract] [Full Text] [Related]
2. NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer. Odunsi K, Jungbluth AA, Stockert E, Qian F, Gnjatic S, Tammela J, Intengan M, Beck A, Keitz B, Santiago D, Williamson B, Scanlan MJ, Ritter G, Chen YT, Driscoll D, Sood A, Lele S, Old LJ. Cancer Res; 2003 Sep 15; 63(18):6076-83. PubMed ID: 14522938 [Abstract] [Full Text] [Related]
3. Ny-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: correlation with tumor grade. Kurashige T, Noguchi Y, Saika T, Ono T, Nagata Y, Jungbluth A, Ritter G, Chen YT, Stockert E, Tsushima T, Kumon H, Old LJ, Nakayama E. Cancer Res; 2001 Jun 15; 61(12):4671-4. PubMed ID: 11406534 [Abstract] [Full Text] [Related]
4. Quantitative real-time RT-PCR analysis of NY-ESO-1 and LAGE-1a mRNA expression in normal tissues and tumors, and correlation of the protein expression with the mRNA copy number. Sato S, Noguchi Y, Wada H, Fujita S, Nakamura S, Tanaka R, Nakada T, Hasegawa K, Nakagawa K, Koizumi F, Ono T, Nouso K, Jungbluth A, Chen YT, Old LJ, Shiratori Y, Nakayama E. Int J Oncol; 2005 Jan 15; 26(1):57-63. PubMed ID: 15586225 [Abstract] [Full Text] [Related]
5. NY-ESO-1 expression and immunogenicity in esophageal cancer. Fujita S, Wada H, Jungbluth AA, Sato S, Nakata T, Noguchi Y, Doki Y, Yasui M, Sugita Y, Yasuda T, Yano M, Ono T, Chen YT, Higashiyama M, Gnjatic S, Old LJ, Nakayama E, Monden M. Clin Cancer Res; 2004 Oct 01; 10(19):6551-8. PubMed ID: 15475443 [Abstract] [Full Text] [Related]
6. Immunohistochemical and molecular analysis of human melanomas for expression of the human cancer-testis antigens NY-ESO-1 and LAGE-1. Vaughan HA, Svobodova S, Macgregor D, Sturrock S, Jungbluth AA, Browning J, Davis ID, Parente P, Chen YT, Stockert E, St Clair F, Old LJ, Cebon J. Clin Cancer Res; 2004 Dec 15; 10(24):8396-404. PubMed ID: 15623618 [Abstract] [Full Text] [Related]
14. Cancer/testis antigen expression and autologous humoral immunity to NY-ESO-1 in gastric cancer. Wang Y, Wu XJ, Zhao AL, Yuan YH, Chen YT, Jungbluth AA, Gnjatic S, Santiago D, Ritter G, Chen WF, Old LJ, Ji JF. Cancer Immun; 2004 Nov 01; 4():11. PubMed ID: 15516106 [Abstract] [Full Text] [Related]
15. Identification of NY-ESO-1, MAGE-1, and MAGE-3 in head and neck squamous cell carcinoma. Kienstra MA, Neel HB, Strome SE, Roche P. Head Neck; 2003 Jun 01; 25(6):457-63. PubMed ID: 12784237 [Abstract] [Full Text] [Related]
16. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance. Yoshida N, Abe H, Ohkuri T, Wakita D, Sato M, Noguchi D, Miyamoto M, Morikawa T, Kondo S, Ikeda H, Nishimura T. Int J Oncol; 2006 May 01; 28(5):1089-98. PubMed ID: 16596224 [Abstract] [Full Text] [Related]
17. Immune responses detected in urothelial carcinoma patients after vaccination with NY-ESO-1 protein plus BCG and GM-CSF. Sharma P, Bajorin DF, Jungbluth AA, Herr H, Old LJ, Gnjatic S. J Immunother; 2008 May 01; 31(9):849-57. PubMed ID: 18833002 [Abstract] [Full Text] [Related]